Since the acquisition, AbbVie has used Allergan’s aesthetics and neuroscience portfolios to diversify its revenue.

If you previously held Allergan (AGN) shares, they were converted during the 2020 merger according to the following terms: AbbVie Completes Transformative Acquisition of Allergan

: Analysts are currently focused on AbbVie's ability to offset the loss of exclusivity for its flagship drug, Humira, through newer immunology drugs like Skyrizi and Rinvoq .

: AbbVie is a known "Dividend King," having consistently increased its dividend for over 50 consecutive years.

Because Allergan has been integrated into AbbVie, you can no longer buy or sell "AGN" shares directly. Instead, investors seeking exposure to Allergan's former portfolio—including and Juvederm —must now trade AbbVie stock. Investment Profile for AbbVie (ABBV)

CrickSoftware
Registered Office
Crick Software Ltd
Crick House, Boarden Close
Moulton Park
Northampton
NN3 6LF
+44 (0) 1604 671691
Follow Crick Software
Copyright © 1993 – 2025 | Crick Software Ltd. | All Rights Reserved
crosschevron-down

Allergan Stock Buy Or Sell -

Since the acquisition, AbbVie has used Allergan’s aesthetics and neuroscience portfolios to diversify its revenue.

If you previously held Allergan (AGN) shares, they were converted during the 2020 merger according to the following terms: AbbVie Completes Transformative Acquisition of Allergan allergan stock buy or sell

: Analysts are currently focused on AbbVie's ability to offset the loss of exclusivity for its flagship drug, Humira, through newer immunology drugs like Skyrizi and Rinvoq . Because Allergan has been integrated into AbbVie, you

: AbbVie is a known "Dividend King," having consistently increased its dividend for over 50 consecutive years. Since the acquisition

Because Allergan has been integrated into AbbVie, you can no longer buy or sell "AGN" shares directly. Instead, investors seeking exposure to Allergan's former portfolio—including and Juvederm —must now trade AbbVie stock. Investment Profile for AbbVie (ABBV)